On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
The approval was driven by data from the Phase III TULIP-SC trial
nSEPIA aims to bring structure to an area long dominated by subjectivity
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
The deal signals a clear push to expand access to care in underserved regions
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Subscribe To Our Newsletter & Stay Updated
